Bristol-Myers Squibb slides as shares trade ex-dividend for $0.63 payout
Bristol-Myers Squibb shares fell about 3% on Thursday, April 2, 2026, largely reflecting the stock trading ex-dividend for its $0.63 quarterly payout. The ex-dividend date also aligns with the record date for the May 1, 2026 payment, creating a mechanical price adjustment and short-term selling pressure.
1) What’s driving the move
Bristol-Myers Squibb is moving lower on April 2, 2026 as the stock trades ex-dividend. When a stock goes ex-dividend, new buyers are no longer entitled to the upcoming dividend, and the share price often adjusts downward by roughly the dividend amount—creating an apparent “drop” even without a fundamental change in the business. (marketbeat.com)
2) Dividend details investors are reacting to
The company’s board declared a quarterly dividend of $0.63 per share, payable May 1, 2026, to shareholders of record as of April 2, 2026. Because April 2 is also listed as the ex-dividend date across multiple market calendars, the day’s weakness fits the typical ex-dividend pattern. (investors.bms.com)
3) Additional context: sentiment and positioning
Beyond the dividend mechanics, recent analyst discussion has centered on how quickly Bristol-Myers’ newer products can offset looming loss-of-exclusivity headwinds. That backdrop can amplify downside on otherwise “technical” down days as some investors use ex-dividend sessions to trim positions or rotate within pharma. (tipranks.com)